Clinical Trial Update: Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating dendritic cell-based immunotherapy for glioblastoma, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Dendritic cell-based immunotherapy

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Glioblastoma | Phase 3 | Status: NOT_YET_RECRUITING